Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Clinically Isolated Syndrome
NCT00094172Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2005
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in clinically isolated syndrome (CIS) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Occurrence of >= 3 New T2 Lesions With or Without Gd+ Enhancement or Clinical Exacerbation at 12 months. Started May 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00094172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094172.